Warren Copp-Howland

This inventor holds 8 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Covidien LP, Tyco Healthcare Group LP, Kpr U.s., LLC. Active years: 2010-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Warren Copp-Howland. Retrieved from https://idiyas.com/inventor/warren-copp-howland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 1.8

ph-index = 3

Forward Citations = 22(Granted Patents)

Company Filing History:

Tyco Healthcare Group LP

Years Active: 2010-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9861807 - System for hydrating defibrillation electrodes (2018-01-09),

2. 9072885 - Systems for hydrating defibrillation electrodes (2015-07-07),

3. 8942830 - Electrode delivery system (2015-01-27),

4. 8428751 - Electrode delivery system (2013-04-23),

5. 8419982 - Conductive compositions and method (2013-04-16),

6. 8017042 - Medical electrode containing a hydrophilic polymer (2011-09-13),

7. 7869855 - Medical apparatus with releasable applicator (2011-01-11),

8. 7761131 - Medical electrode containing a hydrophilic polymer (2010-07-20),

Title: Warren Copp-Howland: Innovator in Defibrillation Technology

Introduction

Warren Copp-Howland is a notable inventor based in Chicopee, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of automated external defibrillators. With a total of 8 patents to his name, his work has had a profound impact on cardiac emergency response.

Latest Patents

Copp-Howland's latest patents include a groundbreaking system for hydrating defibrillation electrodes. This innovative design allows an automated external defibrillator to deliver electrical pulses and shocks to a patient's heart during a cardiac emergency. The defibrillator features a delivery system that includes a pair of electrode pads, each supporting a hydrogel to enhance the effectiveness of the electrical treatment. Additionally, the hydrating system maintains a fluid that hydrates the hydrogel over a predetermined time period, ensuring prolonged effectiveness.

Career Highlights

Throughout his career, Warren Copp-Howland has worked with prominent companies such as Covidien LP and Tyco Healthcare Group LP. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technology.

Collaborations

Copp-Howland has collaborated with talented individuals in the field, including Erick Garstka and David Selvitelli. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Warren Copp-Howland's contributions to defibrillation technology exemplify his commitment to improving cardiac emergency care. His innovative patents and collaborations highlight his role as a key figure in the medical technology landscape.

Profile summary based on public USPTO records.